Zobrazeno 1 - 10
of 167
pro vyhledávání: '"Kelly W. Burak"'
Autor:
Cha Len Lee, Mark Freeman, Kelly W. Burak, Gordon T. Moffat, Conor D. J. O’Donnell, Philip Q. Ding, Hanna Lyubetska, Brandon M. Meyers, Vallerie Gordon, Ekaterina Kosyachkova, Roxana Bucur, Winson Y. Cheung, Jennifer J. Knox, Vincent C. Tam
Publikováno v:
Cancers, Vol 16, Iss 16, p 2878 (2024)
The IMbrave150 trial established atezolizumab with bevacizumab (A+B) as standard care for hepatocellular carcinoma (HCC), recommending an esophagogastroduodenoscopy (EGD) within 6 months of treatment initiation to prevent bleeding from esophagogastri
Externí odkaz:
https://doaj.org/article/f1fa92983f06416981e36c47e6099ff6
Autor:
Nwe Ni Than, James Hodson, Daniel Schmidt-Martin, Richard Taubert, Rebecca E. Wawman, Meemee Botter, Nishant Gautam, Kilian Bock, Rebecca Jones, Gautham D Appanna, Andrew Godkin, Aldo J. Montano-Loza, Frank Lammert, Christoph Schramm, Michael P. Manns, Mark Swain, Kelly W. Burak, David H. Adams, Gideon M Hirschfield, Ye Htun Oo
Publikováno v:
JHEP Reports, Vol 1, Iss 6, Pp 437-445 (2019)
Background & Aims: Treatment options remain limited for patients with autoimmune hepatitis (AIH), while there are still concerns over the consequences of long-term corticosteroid use. A few studies have suggested a role for B cell-driven autoimmune l
Externí odkaz:
https://doaj.org/article/bcb9f7c48c3a4df4a706283363e04ef1
Autor:
Carlos Moctezuma-Velázquez, Gavin Low, Marina Mourtzakis, Mang Ma, Kelly W. Burak, Puneeta Tandon, Aldo J. Montano-Loza
Publikováno v:
Annals of Hepatology, Vol 17, Iss 4, Pp 615-623 (2018)
Introduction and aim. Sarcopenia is an independent predictor of mortality in cirrhosis. Hypogonadism is common in cirrhosis and has been associated with sarcopenia in non-cirrhotic chronic liver disease populations. The aim of this study is to invest
Externí odkaz:
https://doaj.org/article/adc82cd024014cff81f5243f36794ef0
Autor:
Bandar Al-Judaibi, Benson Thomas, Philip Wong, Amine Benmassaoud, Jo-Hua Chen, M. Katherine Dokus, Trana Hussaini, Marc Bilodeau, Kelly W. Burak, Paul Marotta, Eric. M. Yoshida
Publikováno v:
Annals of Hepatology, Vol 17, Iss 3, Pp 437-443 (2018)
Introduction and aim. Sofosbuvir (SOF)-based regimen has been shown to have high efficacy even in patients with decompensated cirrhosis. Treated patients may experience various degrees of hepatic recovery ranging from stabilization of liver function,
Externí odkaz:
https://doaj.org/article/1623f135bab448269e21471b5f0e8fb8
Autor:
Conar R. O’Neil, Stephen E. Congly, M. Sarah Rose, Samuel S. Lee, Meredith A. Borman, Carmen L. Charlton, Carla Osiowy, Mark G. Swain, Kelly W. Burak, Carla S. Coffin
Publikováno v:
Annals of Hepatology, Vol 17, Iss 2, Pp 232-241 (2018)
Introduction. Quantitative hepatitis B surface antigen (qHBsAg) combined with HBV DNA may be useful for predicting chronic hepatitis B (CHB) activity and nucleoside analogue (NA) response.Material and methods. In this retrospective cohort study we ev
Externí odkaz:
https://doaj.org/article/d56f55c5c6ec4b9bbba337622c1451a5
Publikováno v:
Case Reports in Medicine, Vol 2019 (2019)
Background. Spontaneous regression of hepatocellular carcinoma (HCC) is a rare event, although it has been described by numerous groups. The long-term fate of individuals experiencing an SR is not well described, and the underlying mechanism(s) of SR
Externí odkaz:
https://doaj.org/article/8b8cf9fb7f864f34a5a2f1ba088a92f5
Publikováno v:
Microorganisms, Vol 8, Iss 10, p 1470 (2020)
Chronic Hepatitis B Virus (HBV) infection poses a significant global health burden. Although, effective treatment and vaccinations against HBV are available, challenges still exist, particularly in the development of curative therapies. The dynamic n
Externí odkaz:
https://doaj.org/article/7cb7840649c049dd8bcd6e00700974bb
Autor:
Nabiha Faisal, MD, FCPS, Eric M. Yoshida, Marc Bilodeau, Philip Wong, Mang Ma, Kelly W. Burak, Bandar Al-Judaibi, Eberhard L. Renner, Leslie B. Lilly
Publikováno v:
Annals of Hepatology, Vol 13, Iss 5, Pp 525-532 (2014)
Introduction. Hepatitis C (HCV) continues to be the leading indication for liver transplantation (LT). Sustained virological response (SVR) rates to pegylated interferon (PEG-IFN) and ribavirin (RBV) therapy for recurrent HCV in Genotype 1 (G1) LT re
Externí odkaz:
https://doaj.org/article/844f8a7d86274a84abe445e26c0ea2e5
Autor:
Kelly W. Burak, Glenda A. Meeberg, Robert P. Myers, Gordon H. Fick, Mark G. Swain, Vincent G. Bain, Norman M. Kneteman, Robert J. Hilsden
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2016 (2016)
Background. Since 2002, the Model of End-Stage Liver Disease (MELD) has been used for allocation of liver transplants (LT) in the USA. In Canada, livers were allocated by the CanWAIT algorithm. The aim of this study was to compare the abilities of ME
Externí odkaz:
https://doaj.org/article/db3d73cf4ecc4e3ba6179e469fc0a347
Autor:
Kelly W. Burak, Maitreyi Raman, Michael Paget, Kevin Busche, Sylvain Coderre, Kevin McLaughlin
Publikováno v:
Education Sciences, Vol 7, Iss 4, p 83 (2017)
The flipped classroom model is increasingly being adopted in healthcare education, despite the fact that recent systematic reviews in the nursing and medical education literature suggest that this method of instructional design is not inherently bett
Externí odkaz:
https://doaj.org/article/1705414ba2824bbdbd143af4885393cc